Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

  1. Allocca, M.
  2. Catalano, G.
  3. Savarino, E.V.
  4. Chaparro, M.
  5. Levartovsky, A.
  6. Michalopoulos, G.
  7. Viazis, N.
  8. Fousekis, F.S.
  9. Psistakis, A.
  10. Noviello, D.
  11. Nascimento, C.N.D.
  12. Caron, B.
  13. Kitsou, V.
  14. Bamias, G.
  15. García, M.J.
  16. Zacharopoulou, E.
  17. Foteinogiannopoulou, K.
  18. D'Amico, F.
  19. Koutroubakis, I.
  20. Ellul, P.
  21. Tzouvala, M.
  22. Peyrin-Biroulet, L.
  23. Torres, J.
  24. Caprioli, F.
  25. Karmiris, K.
  26. Theodoropoulou, A.
  27. Katsanos, K.H.
  28. Christodoulou, D.K.
  29. Mantzaris, G.J.
  30. Kopylov, U.
  31. Gisbert, J.P.
  32. Danese, S.
  33. Magro, F.
  34. Carla, F.
  35. Fiorino, G.
  36. Mostra tots els autors/es +
Revista:
United European Gastroenterology Journal

ISSN: 2050-6414,  2050-6406

Any de publicació: 2024

Tipus: Article

DOI: 10.1002/UEG2.12492 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus